Skip to content

A study of efficacy and safety of pneumatic needleless micro-jet injector for the treatment of striae distensae

A study of efficacy and safety of pneumatic needleless micro-jet injector for the treatment of striae distensae

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171223001
Enrollment
30
Registered
2017-12-23
Start date
2017-09-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal striae distensae

Interventions

The first section of abdominal striae is treated with pneumatic needleless micro&#45
jet injector with diluted hyaluronic acid filler.,The second section is treated with pneumatic needleless micro&#45
jet injector with normal saline solution.,The third section is left untreated to serve as control arm.
pneumatic needleless micro&#45
jet injector with hyaluronic acid filler,pneumatic needleless micro&#45
jet injector with normal saline,untreated

Sponsors

Division of Dermatology, Department of Medicine, Faculty of Medicine, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age of 18 years or older 2. having stable striae distensae on lower abdominal area without change for at least 6 months 3. willing to return for every required follow-up visits 4. capacity to giving written informed consent

Exclusion criteria

Exclusion criteria: 1. pregnancy and lactation 2. history of allergy to hyaluronic acid, fillers, or local anesthesia 3. having topical drugs, injectables, devices, or surgery 1 year prior to recruitment 4. history of tanning within 1 month 5. history of connective tissue disease or keloid 6. having infection, dermatitis, skin cancer, or abnormal skin condition in treatment area 7. immunocompromised host 8. taking isotretinoin 1 year prior to recruitment 9. unable to follow the protocol

Design outcomes

Primary

MeasureTime frame
Physician assesment week 0, 4, 8, 20, 32 visual analog scale of color, texture, degree of atrophy

Secondary

MeasureTime frame
Histopathological assessment week 0, 8 evaluation of dermal collagen and elastin

Countries

Thailand

Contacts

Public ContactSalinee Rojhirunsakool

Nil

tibra133@yahoo.com0855016292

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026